Oculis Updates Share Capital
Oculis Holding AG (Nasdaq: OCS) has announced an update to its share capital structure. The company has issued 589,974 new registered ordinary shares with a nominal value of CHF 0.01 each. This issuance consists of:
- 310,941 shares issued for equity awards under the Company's Stock Option and Incentive Plan
- 279,033 shares issued through EBAC warrant exercises
Following these issuances, which occurred between January 1, 2024, and December 31, 2024, Oculis's total registered shares have increased to 54,533,674. The change has been officially registered with the Zug Commercial Register.
Oculis Holding AG (Nasdaq: OCS) ha annunciato un aggiornamento della sua struttura del capitale sociale. La società ha emesso 589.974 nuove azioni ordinarie nominative del valore nominale di CHF 0,01 ciascuna. Questa emissione comprende:
- 310.941 azioni emesse come premi azionari nell'ambito del Piano di Stock Option e Incentivi della Società
- 279.033 azioni emesse tramite l'esercizio dei warrant EBAC
In seguito a queste emissioni, avvenute tra il 1° gennaio 2024 e il 31 dicembre 2024, il totale delle azioni registrate di Oculis è aumentato a 54.533.674. La modifica è stata ufficialmente registrata presso il Registro Commerciale di Zug.
Oculis Holding AG (Nasdaq: OCS) ha anunciado una actualización en la estructura de su capital social. La compañía ha emitido 589.974 nuevas acciones ordinarias nominativas con un valor nominal de CHF 0,01 cada una. Esta emisión consta de:
- 310.941 acciones emitidas como premios de capital bajo el Plan de Opciones sobre Acciones e Incentivos de la Compañía
- 279.033 acciones emitidas mediante el ejercicio de warrants EBAC
Tras estas emisiones, que tuvieron lugar entre el 1 de enero de 2024 y el 31 de diciembre de 2024, el total de acciones registradas de Oculis ha aumentado a 54.533.674. El cambio ha sido registrado oficialmente en el Registro Mercantil de Zug.
Oculis Holding AG (나스닥: OCS)가 자본 구조 변경을 발표했습니다. 회사는 액면가 CHF 0.01의 신주 589,974주를 등록 보통주로 발행했습니다. 이번 발행은 다음과 같습니다:
- 회사의 스톡옵션 및 인센티브 계획에 따른 주식 보상으로 310,941주 발행
- EBAC 워런트 행사로 279,033주 발행
2024년 1월 1일부터 2024년 12월 31일 사이에 이루어진 이번 발행으로 Oculis의 총 등록 주식 수는 54,533,674주로 증가했습니다. 이 변경 사항은 Zug 상업 등기소에 공식 등록되었습니다.
Oculis Holding AG (Nasdaq : OCS) a annoncé une mise à jour de la structure de son capital social. La société a émis 589 974 nouvelles actions ordinaires nominatives d'une valeur nominale de CHF 0,01 chacune. Cette émission se compose de :
- 310 941 actions émises dans le cadre des attributions d'actions selon le Plan d'Options d'Achat d'Actions et d'Incentives de la Société
- 279 033 actions émises suite à l'exercice de bons de souscription EBAC
Suite à ces émissions, intervenues entre le 1er janvier 2024 et le 31 décembre 2024, le nombre total d'actions nominatives d'Oculis est passé à 54 533 674. La modification a été officiellement enregistrée au registre du commerce de Zug.
Oculis Holding AG (Nasdaq: OCS) hat eine Aktualisierung seiner Kapitalstruktur bekanntgegeben. Das Unternehmen hat 589.974 neue eingetragene Stammaktien mit einem Nennwert von jeweils CHF 0,01 ausgegeben. Diese Ausgabe besteht aus:
- 310.941 Aktien, die als Kapitalzuteilungen im Rahmen des Aktienoptions- und Anreizplans des Unternehmens ausgegeben wurden
- 279.033 Aktien, die durch Ausübung von EBAC-Warrants ausgegeben wurden
Nach diesen Ausgaben, die zwischen dem 1. Januar 2024 und dem 31. Dezember 2024 erfolgten, erhöhte sich die Gesamtzahl der eingetragenen Aktien von Oculis auf 54.533.674. Die Änderung wurde offiziell im Handelsregister von Zug eingetragen.
- None.
- None.
ZUG, Switzerland, April 25, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company, has issued registered ordinary shares of the Company, each with a nominal value of CHF 0.01. The issuance comprises 589,974 registered shares, reflecting the settlement of 310,941 shares issued in connection with the exercise of equity awards under the Company’s Stock Option and Incentive Plan Regulation and 279,033 shares issued through EBAC warrant exercises pursuant to the Company‘s Articles of Association, during the period from January 1, 2024, to December 31, 2024.
As a result, the total number of registered shares as set forth in the Company’s Articles of Association has increased to 54,533,674. This increase has been registered with the Zug Commercial Register.
For more information, please visit:
http://www.oculis.com
Oculis Contact:
Ms. Sylvia Cheung, CFO
sylvia.cheung@oculis.com
Investor & Media Relations:
LifeSci Advisors
Corey Davis, Ph.D.
cdavis@lifesciadvisors.com
FAQ
How many new shares did Oculis (OCS) issue in 2024?
What is the total number of registered shares for Oculis (OCS) after the 2024 issuance?
What was the purpose of Oculis's (OCS) share issuance in 2024?
What is the nominal value of Oculis's (OCS) newly issued shares?
